Need some investing ideas? Here’s the latest from our popular Strong Buy Stocks from Top Wall Street Analysts screener:
- Why analysts believe Liveramp (RAMP) could nearly double in the coming year
-
MasTec (MTZ) has an impressive backlog that could lead to long-term gains
- Analysts have great confidence in Idexx Laboratories’ (IDXX) near-term growth prospects
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
The ChatGPT Moment for Money Has Arrived-Introducing NatGold
AI changed intelligence; NatGold changes money. Digitally mined, sustainably produced, and backed by real gold reserves, NatGold is redefining how wealth is stored and traded. Reserve your tokens at a special 10% discount available only for the first 10,000 early investors-before the world wakes up.
Act now to secure your discounted NatGold Tokens and be part of the next financial breakthrough.
Idexx Laboratories is a dominant player in veterinary diagnostics, software, and water testing — and currently operates in a whopping 175 countries. IDXX has rallied by 60.95% since the start of the year — the company recently delivered a double beat, and its impressive balance sheet is more than enough to support further growth.
Zen Rating: B (Buy) — see full analysis >
Recent Price: $658.06 — get current quote >
Max 1-year forecast: $675.00
Why we’re watching:
- IDXX shares currently have 2 Strong Buy ratings, 1 Buy rating, and 3 Hold ratings. See the ratings
-
Chris Schott of JP Morgan (a top 23% rated analyst) doubled down on a Strong Buy rating on the stock following the company’s Q2 2025 earnings and hiked his price target from $550 to a Street-high $675.
- In general, the print was positive, with results above expectations, InVue Dx's launch getting off to a promising start, and management raising its 2025 guidance, Schott told readers.
- Although unfavorable investor positioning is impacting the stock's post-print momentum, the analyst said they increased their estimates because of greater confidence in Idexx Laboratories' new launch trends and near-term growth guidance.
- Schott added that they remain satisfied that the company can achieve long-term sustainable growth in the double digits.
- Idexx Laboratories stock ranks in the top 9% of the equities we track, giving it a Zen Rating of B, which corresponds to an average annual return of 19.88%.
- Our Safety Component Grade rating is a measure of stock price stability, revenue inflow stability, and how predictable a ticker’s earnings are. In this regard, IDXX ranks in the top 20% of equities.
- A stock’s Artificial Intelligence rating is derived from the findings of a neural network trained on two decades of market data. In this category, Idexx Laboratories shares rank in the top 19%.
-
However, Financials are the star of the show — as IDXX ranks in the 98th percentile of equities in terms of its balance sheet. (See all 7 Zen Component Grades here >)
MasTec is an infrastructure construction business — but there’s an important twist. The business specializes in electrical transmission networks, 5G deployment, and renewable energy infrastructure. More recently, it has also expanded into data centers. Per a recent earnings report, our latest pick also has a record-breaking $15.9 billion backlog. However, it is the MTZ’s growth potential going forward that makes it worth a closer look.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $181.30 — get current quote >
Max 1-year forecast: $227.00
Why we’re watching:
- MTZ enjoys broad, nearly unanimous bullish support from Wall Street equity researchers. The stock currently has 14 Strong Buy ratings and 1 Hold rating. See the ratings
- Following the company’s Q2 2025 earnings call, Citigroup researcher Andy Kaplowitz (a top 1% rated analyst) reiterated a Strong Buy rating on the stock and adjusted his price forecast from $220 to $219.
- Noting that the quarter beat on earnings and management raised its FY 2025 guidance, Kaplowitz called the post-print selloff "somewhat overdone."
- MasTec is currently the 7th highest-rated stock in the Engineering & Construction industry, which has an Industry Rating of A.
- MTZ ranks in the 96th percentile of the equities that our system tracks, giving it a Zen Rating of A.
- There’s plenty to like here — for instance, the stock ranks in the top 14% when it comes to both Sentiment and Safety.
- MasTec shares have rallied by 29.51% since the start of the year, and rank in the 89th percentile in terms of Momentum.
- Growth, however, is MTZ’s strongest suit — in this category, the stock ranks in the top 1% of the equities that we track. (See all 7 Zen Component Grades here >)
LiveRamp isn’t just a crucial data connectivity provider — it’s a previous holding in the market-beating Zen Investor portfolio. In an era where data security is becoming a top priority, RAMP has seen stellar returns on account of its proven business model. The company recently delivered a double beat, but the stock has dropped on account of profit-taking — so it’s currently trading at a discount.
Zen Rating: A (Strong Buy) — see full analysis >
Recent Price: $26.46 — get current quote >
Max 1-year forecast: $53.00
Why we’re watching:
- RAMP shares are covered by 4 Wall Street analysts — their coverage is split between 2 Strong Buy ratings and 2 Hold ratings. See the ratings
- However, the average price target for LiveRamp stock, currently pegged at $40.75, implies a hefty 54.01% upside.
- Benchmark researcher Mark Zgutowicz (a top 15% rated analyst) maintained a Strong Buy rating on RAMP following the company’s Q1 2026 earnings call, and increased his price target from $51 to a Street-high $53.
- Zgutowicz highlighted that the quarter delivered subscription revenue and operating income beats.
- Looking ahead, the analyst told readers that management is sure the launch of its new pricing model last month, which will transition the company from a generally high-fixed pricing model to a lower cost-based usage model, will produce "many more wins" in the Commerce Media sector.
- LiveRamp is currently the 4th highest-rated stock in the Software Infrastructure industry, which has an Industry Rating of A.
- Our quant rating system, Zen Ratings, uses 115 proprietary factors to evaluate stocks. It puts RAMP in the top 3% of stocks, giving it a Zen Rating of A — stocks with this distinction have, on average, provided an annual return of 32.52% since the early 2000s.
- Each Zen Rating is a composite of seven Component Grade ratings. For instance, LiveRamp scores highly in two categories — Value and Growth.
- When it comes to Value, RAMP is trading at a price-to-earnings growth (PEG) ratio of just 0.67x — so it’s no wonder that it ranks in the 92nd percentile in this category.
- However, Growth is the main selling point here — LiveRamp shares rank in the top 2% of the more than 4,600 equities that we track in this regard. (See all 7 Zen Component Grades here >)
What to Do Next?